Abstract
A bleeding tendency, associated with renal failure, has been recognized since the eighteenth century (Riesman 1907), but its pathogenesis has only recently been elucidated. The availability of dialysis has reduced the incidence of bleeding episodes, and the early use of dialysis in acute and chronic renal failure has been particularly effective in this respect. There certainly exists a difference in the severity of bleeding between patients suffering from acute renal failure compared with those with chronic renal failure. The bleeding tendency in chronic renal failure is usually mild; it is restricted to mucocutaneous sites, being manifest as epistaxis, petechiae and increased bleeding from wounds. This is different from severe haemorrhage, which may occur in patients with acute renal failure; severe bleeding may also occur in patients with end-stage renal failure when they are dialysed for the first time. The additional effects of drugs, required for the adequate treatment of patients suffering from renal failure, may further contribute to any bleeding tendency, as will be discussed. For the sake of clarity, the bleeding tendency caused by chronic renal failure, acute renal failure and dialysis will be considered separately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrassy K (1985) Antithrombin III. Urban & Schwarzenberg, München
Andrassy K, Ritz E (1977) Penicillin and haemostasis. Cardiovasc Med 2: 604–608
Andrassy K, Ritz E (1985) Uremia as a cause of bleeding. Am J Nephrol 5: 313–319
Andrassy K, Malluche H. Bornefeld H, Cornberg M, Ritz E, Jesdinsky H, Möhring K (1974) Prevention of p.o. clotting of av. Cimino fistulae with acetylsalicylic acid. Results of a prospective double blind study. Klin Wochenschr 52: 348–349
Andrassy K, Ritz E, Hasper P, Scherz M, Walter E, Storch H, Vömel W (1976a) Penicillin-induced coagulation disorder. Lancet II: 1039–1041
Andrassy K, Weisschedel E, Ritz E, Andrassy T (1976b) Bleeding in uraemic patients after carbenicillin. Thromb Haemost 36: 115–126
Andrassy K, Ritz E, Bommer J (1987) Effects of hemodialysis on platelets. Contrib Nephrol 59:26–34
Andrassy K, Koderisch J, Lamminger C (1988) Defective platelet membrane receptors as a cause of uraemic bleeding. Blut 53: 243
Caruana RJ, Raja RM, Bush JV, Kramer MS, Goldstein SJ (1988) Heparin free dialysis: comparative data and results in high risk patients. Kidney Int 31: 1351–1355
Castillo R, Lozano T, Escolar G, Revert L (1986) Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 68: 337–342
Colman RW, Robboy SJ, Minna JD (1972) Disseminated intravascular coagulation: an approach. Am J Med 52: 679–689
Deykin D (1983) Uremic bleeding. Kidney Int 24: 698–705
Docci D, Turci F, Delvecchio C, Gollini C, Baldrati L, Pistocchi E (1986) Lack of evidence for the role of secondary hyperparathyroidism in the pathogenesis of uremic thrombocytopathy. Nephron 43: 28–32
Editorial (1987) Unravelling HUS. Lancet II: 1437–1439
Eknoyan G, Brown CH (1981) Biochemical abnormalities of platelets in renal failure. Am J Nephrol 1: 17–23
Eknoyan G, Wacksman S, Glueck H, Will J (1969) Platelet function in renal failure. N Engl J Med 280: 677–681
Gaspari F, Vigano G, Orisio S, Bonati M, Livio M, Remuzzi G (1987) Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 79: 1788–1797
George JN, Nurden AT, Phillips DR (1984) Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 311: 1084–1098
Goldstein MH, Churg J, Strauss L, Gribetz D (1979) Hemolytic-uremic syndrome. Nephron 23:263–272
Gura V, Creter D, Levi J (1982) Elevated thrombocyte calcium in uremia and its correction by la (OH) vitamin D treatment. Nephron 30: 237–239
Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D (1980) Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318–1322
Jaques LB (1980) Heparins: anionic polyelectrolyte drugs. Pharmacol Rev 31: 99–166
Lindsay RM, Ferguson D, Prentice CRM, Burton JA, McNicol GP (1972) Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet I: 1287–1290
Lipsky JJ (1983) N-Methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet II: 192–193
Livio M, Gotti E, Marchesi E, Mecca G, Remuzzi G, De Gaetano G (1982) Uraemie bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet II: 1013–1015
Livio M, Mannucci PM, Vigano G, Mingardi G, Lombardi R, Mecca G, Remuzzi G (1986) Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315: 731–735
Massry SG, Goldstein DA (1979) The search for uremic toxin(s) X × X = PTH. Clin Nephrol 11:181–189
Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Pontieelli C (1987) Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoetin. Lancet II: 1227–1229
Pinnick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308: 258–261
Remuzzi G (1987) HUS and TTP: variable expression of a single entity. Kidney Int 32: 292–308
Remuzzi G, Pusineri F (1988) Coagulation defects in uremia. Kidney Int 33 (Suppl 24): S13-S17
Remuzzi G, Cavenaghi A, Mecca G, Donati M (1977) Prostacyclin-like activity and bleeding in renal failure. Lancet II: 1195–1197
Remuzzi G, Benigni A, Dodesini P, Schiepatti A (1981) Parathyroid hormone inhibits human platelet function. Lancet II: 1321–1323
Riesman D (1907) Hemorrhages in the course of Bright’s disease with especial reference to the occurrence of a hemorrhagic diathesis of nephrotic origin. Am J Sci 134: 709–716
Shearer MJ, Bechtold H, Andrassy K, Koderisch J, McCarthy PT, Trenk D, Jahnchen E, Ritz E (1988) Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 28: 88–95
Smith MC, Crow JW, Cato AE, Park GD, Hassid A, Dunn MJ (1982) Prostacyclin substitution for heparin in long-term hemodialysis. Am J Med 73: 669–678
Steiner R, Coggins C, Carvalho A (1979) Bleeding time in uraemia: a useful test to assess clinical bleeding. Am J Haematol 7: 101–117
Stewart J, Castaldi P (1967) Uremic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36: 409–423
Watson AJS, Keogh JAB (1982) Effect off l-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 32: 49–52
Weinstein L, Klainer AS (1966) Septic shock — pathogenesis and treatment. N Engl J Med 274: 950–953
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andrassy, K. (1990). Bleeding in Acute Renal Failure. In: Bihari, D., Neild, G. (eds) Acute Renal Failure in the Intensive Therapy Unit. Current Concepts in Critical Care. Springer, London. https://doi.org/10.1007/978-1-4471-1750-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1750-6_21
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1752-0
Online ISBN: 978-1-4471-1750-6
eBook Packages: Springer Book Archive